Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The following outline is based on clinical practices and published usage patterns among healthcare providers: Initial phase: 2.0-2.5 mg administered subcutaneously or intramuscularly every other day
Key additional potential side effects: Hypersensitivity reaction
Lastly, we tested whether cells that were functionally deficient in mitochondrial ETC metabolism, owing to mutations in CI and CIV, were differentially sensitive to 5FU treatment
Sollten Sie mit unserem Produkt nicht zufrieden sein, oder aber Hilfe und Beratung bentigen, kontaktieren Sie uns gerne
US$ 28.54
US$ 22.08
US$ 21.51
